炎症微环境:肝肿瘤细胞和肝肿瘤干细胞中的问题
Inflammatory Microenvironment: Problems of Liver Tumor Cells and Liver Cancer Stem Cells
摘要: 持续的炎症会促进和加重恶性肿瘤。原发性肝癌,主要是肝细胞癌(HCC),是炎症相关癌症的一个明显例子。炎症微环境在HCC发生发展的各阶段起着不可忽视的作用,因此,在确定治疗策略时应充分考虑炎症微环境的影响。概述HCC炎症微环境的组成及该环境对肝癌细胞和肝癌肿瘤干细胞影响的关键问题,探讨其在靶向治疗和免疫治疗盛行时代中的机遇和挑战。
Abstract: Persistent inflammation promotes and aggravates malignancy. Primary liver cancer, mainly hepatocellular carcinoma (HCC), is an obvious example of inflammation-related cancers. The role of the inflammatory microenvironment in the development of HCC cannot be ignored at all stages, therefore, the impact of the inflammatory microenvironment is fully considered in determining treatment strategies. This paper summarizes the composition of the inflammatory microenvironment of HCC and the key issues of the impact of this environment on HCC cells and HCC cancer stem cells, and explores its opportunities and challenges in the prevailing era of targeted therapy and immunotherapy.
文章引用:熊凌风, 区奕猛. 炎症微环境:肝肿瘤细胞和肝肿瘤干细胞中的问题[J]. 临床医学进展, 2021, 11(10): 4591-4603. https://doi.org/10.12677/ACM.2021.1110675

参考文献

[1] Parkin, D.M., Pisani, P., Muñoz, N. and Ferlay, J. (1999) The Global Health Burden of Infection. In: Newton, R., Beral, V. and Weiss, R.A., Eds., Infections and Human Cancer, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 5-33.
[2] Yao, R.R., Li, J.H., Zhang, R., Chen, R.X. and Wang, Y.H. (2018) M2-Polarized Tumor-Associated Macrophages Facilitated Migration Epithelial-Mesenchymal Transition of HCC Cells via the TLR4/STA T3 Signaling Pathway. World Journal of Surgical Oncology, 16, 9. [Google Scholar] [CrossRef] [PubMed]
[3] Edmunds, W.J., et al. (1993) The Influence of Age on the Development of the Hepatitis B Carrier State. Proceedings of the Royal Society B: Biological Sciences, 253, 197-201. [Google Scholar] [CrossRef] [PubMed]
[4] Castello, G., et al. (2010) HCV-Related Hepatocellular Carcinoma: From Chronic Inflammation to Cancer. Clinical Immunology, 134, 237-250. [Google Scholar] [CrossRef] [PubMed]
[5] Zheng, L., You, N., Huang, X., Gu, H., Wu, K., Mi, N. and Li, J. (2019) COMMD7 Regulates NF-kappaB Signaling Pathway in Hepatocellular Carcinoma Stem-Like Cells. Molecular Therapy—Oncolytics, 12, 112-123. [Google Scholar] [CrossRef] [PubMed]
[6] Porta, C., Riboldi, E. and Sica, A. (2011) Mechanisms Linking Pathogens-Associated Inflammation and Cancer. Cancer Letters, 305, 250-262. [Google Scholar] [CrossRef] [PubMed]
[7] Leonardi, G.C., Candido, S., Cervello, M., et al. (2012) The Tumor Microenvironment in Hepatocellular Carcinoma. International Journal of Oncology, 40, 1733-1747.
[8] Luedde, T. and Schwabe, R.F. (2011) NF-κB in the Liver-Linking Injury, Fibrosis and Hepatocellular Carcinoma. Nature Review Gastroenterology and Hepatology, 8, 108-118. [Google Scholar] [CrossRef] [PubMed]
[9] Yang, J.D., Nakamura, I. and Roberts, L.R. (2011) The Tumor Microenvironment in Hepatocellular Carcinoma: Current Status and Therapeutic Targets. Seminars in Cancer Biology, 21, 35-43. [Google Scholar] [CrossRef] [PubMed]
[10] Giannitrapani, L., Cervello, M., Soresi, M., Notarbartolo, M., La Rosa, M., Virruso, L., D’Alessandro, N. and Montalto, G. (2002) Circulating IL-6 and sIL-6R in Patients with Hepatocellular Carcinoma. Annals of the New York Academy of Sciences, 963, 46-52. [Google Scholar] [CrossRef] [PubMed]
[11] Roberts, L.R. (2016) Biomarkers for Hepatocellular Carcinoma. Gastroenterology & Hepatology, 12, 252-255.
[12] Kao, J.T., Feng, C.L., Yu, C.J., Tsai, S.M., Hsu, P.N., Chen, Y.L. and Wu, Y.Y. (2015) IL-6, through p-STAT3 Rather than p-STAT1, Activates Hepatocarcinogenesis and Affects the Survival of Hepatocellular Carcinoma Patients: A Cohort Study. BMC gastroenterology, 15, 50. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, R., Tang, C., Shen, A., et al. (2016) IL-37 Suppresses Hepatocellular Carcinoma Growth by Converting pSmad3 Signaling from JNK/pSmad3L/c-Myc Oncogenic Signaling to pSmad3C/P21 Tumor-Suppressive Signaling. Oncotarget, 7, 85079-85096. [Google Scholar] [CrossRef] [PubMed]
[14] Lee, Y.J. and Jang, B.K. (2015) The Role of Autophagy in Hepatocellular Carcinoma. International Journal of Molecular Sciences, 16, 26629-26643. [Google Scholar] [CrossRef] [PubMed]
[15] Li, T.T., Zhu, D., Mou, T., et al. (2017) IL-37 Induces Autophagy in Hepatocellular Carcinoma Cells by Inhibiting the PI3K/AKT/mTOR Pathway. Molecular Immunology, 87, 132-140. [Google Scholar] [CrossRef] [PubMed]
[16] Xiang, Z.L., et al. (2009) Chemokine Receptor CXCR4 Expression in Hepatocellular Carcinoma Patients Increases the Risk of Bone Metastases and Poor Survival. BMC Cancer, 9, 176. [Google Scholar] [CrossRef] [PubMed]
[17] Du, D., et al. (2014) The Effects of the CCR6/CCL20 Biological Axis on the Invasion and Metastasis of Hepatocellular Carcinoma. International Journal of Molecular Sciences, 15, 6441-6452. [Google Scholar] [CrossRef] [PubMed]
[18] Yeung, O.W., et al. (2015) Alternatively, Activated (M2) Macrophages Promote Tumor Growth and Hepatocellular Carcinoma Invasiveness. Journal of Hepatology, 62, 607-616. [Google Scholar] [CrossRef] [PubMed]
[19] Leng, J., Han, C., Demetris, A.J., et al. (2003) Cyclooxygenase-2 Promotes Hepatocellular Carcinoma Cell Growth through Akt Activation: Evidence for Akt Inhibition in Celecoxib Induces Apoptosis. Hepatology, 38, 756-768. [Google Scholar] [CrossRef] [PubMed]
[20] Dajani, O.F., Meisdalen, K., Guren, T.K., Aasrum, M., Tveteraas, I.H., Lilleby, P., Thoresen, G.H., Sandnes, D. and Christoffersen, T. (2008) Prostaglandin E2 Upregulates EGF-Stimulated Signaling in Mitogenic Pathways Involving Akt and ERK in Hepatocytes. Journal of Cellular Physiology, 214, 371-380. [Google Scholar] [CrossRef] [PubMed]
[21] Hatziapostolou, M., Polytarchou, C., Aggelidou, E., Drakaki, A., Poultsides, G.A., Jaeger, S.A., Ogata, H., Karin, M., Struhl, K., Hadzopoulou-Cladaras, M. and Iliopoulos, D. (2011) An HNF4α-miRNA an Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis. Cell, 147, 1233-1247. [Google Scholar] [CrossRef] [PubMed]
[22] Bonavita, E., Gentile, S., Rubino, M., Maina, V., Papait, R., Kunderfranco, P., et al. (2015) PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer. Cell, 160, 700-714. [Google Scholar] [CrossRef] [PubMed]
[23] Rava, M., D’Andrea, A., Doni, M., Kress, T.R., Ostuni, R., Bianchi, V., et al. (2017) Mutual Epithelium-Macrophage Dependency in Liver Carcinogenesis Mediated by ST18. Hepatology (Baltimore, Md), 65, 1708-1719. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, D., Yang, L., Yue, D., Cao, L., Li, L., Wang, D., et al. (2019) Macrophage-Derived CCL22 Promotes an Immunosuppressive Tumor Microenvironment via IL-8 in Malignant Pleural Effusion. Cancer Letters, 452, 244-253. [Google Scholar] [CrossRef] [PubMed]
[25] Yin, C., Evason, K.J., Asahina, K. and Stainier, D.Y.R. (2013) Hepatic Stellate Cells in Liver Development, Regeneration, and Cancer. Journal of Clinical Investigation, 123, 1902-1910. [Google Scholar] [CrossRef
[26] Chen, Y., Choi, S.S., Michelotti, G.A., Chan, I.S., Swiderska-Syn, M., Karaca, G.F., et al. (2012) Hedgehog Controls Hepatic Stellate Cell Fate by Regulating Metabolism. Gastroenterology, 143, 1319-1329. [Google Scholar] [CrossRef] [PubMed]
[27] Maeda, S., Kamata, H., Luo, J.L., Leffert, H. and Karin, M. (2005) IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation That Promotes Chemical Hepatocarcinogenesis. Cell, 121, 977-990. [Google Scholar] [CrossRef] [PubMed]
[28] Maed, S., Hikiba, Y., Sakamoto, K., Nakagawa, H., Hirata, Y., Hayakawa, Y., Yanai, A., Ogura, K., Karin, M. and Omata, M. (2009) I Kappa B Kinase Beta/Nuclear Factor-kappaB Activation Controls the Development of Liver Metastasis by Way of Interleukin-6 Expression. Hepatology, 50, 1851-1860. [Google Scholar] [CrossRef] [PubMed]
[29] Taub, R. (2003) Hepatoprotection via the IL-6/Stat3 Pathway. Journal of Clinical Investigation, 112, 978-980. [Google Scholar] [CrossRef
[30] Van Hees, S., Michielsen, P. and Vanwolleghem, T. (2016) Circulating Predictive and Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma. World Journal of Gastroenterology, 22, 8271. [Google Scholar] [CrossRef] [PubMed]
[31] Kao, J.-T., Feng, C.-L., Yu, C.-J., Tsai, S.-M., Hsu, P.-N., Chen, Y.-L. and Wu, Y.-Y. (2015) IL-6, through p-STAT3 Rather than p-STAT1, Activates Hepatocarcinogenesis and Affects the Survival of Hepatocellular Carcinoma Patients: A Cohort Study. BMC Gastroenterology, 15, 50. [Google Scholar] [CrossRef] [PubMed]
[32] He, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H.L. and Karin, M. (2010) Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation. Cancer Cell, 17, 286-297. [Google Scholar] [CrossRef] [PubMed]
[33] Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P. and Zucman-Rossi, J. (2009) Frequent In-Frame Somatic Deletions Activate gp130 in Inflammatory Hepatocellular Tumors. Nature, 457, 200. [Google Scholar] [CrossRef] [PubMed]
[34] Kusaba, M., Nakao, K., Goto, T., Nishimura, D., Kawashima, H., Shibata, H., Motoyoshi, Y., Taura, N., Ichikawa, T. and Hamasaki, K. (2007) Abrogation of Constitutive STAT3 Activity Sensitizes Human Hepatoma Cells to TRAIL-Mediated Apoptosis. Journal of Hepatology, 47, 546-555. [Google Scholar] [CrossRef] [PubMed]
[35] Jiang, R., Tan, Z., Deng, L., Chen, Y., Xia, Y., Gao, Y., Wang, X. and Sun, B. (2011) Interleukin-22 Promotes Human Hepatocellular Carcinoma by Activation of STAT3. Hepatology, 54, 900-909. [Google Scholar] [CrossRef] [PubMed]
[36] Mercer, T.R., Dinger, M.E. and Mattick, J.S. (2009) Long Non-Coding RNAs: Insights into Functions. Nature Reviews Genetics, 10, 155. [Google Scholar] [CrossRef] [PubMed]
[37] Cheng, C.J., Bahal, R., Babar, I.A., Pincus, Z., Barrera, F., Liu, C., et al. (2015) MicroRNA Silencing for Cancer Therapy Is Targeted to the Tumor Microenvironment. Nature, 518, 107-110. [Google Scholar] [CrossRef] [PubMed]
[38] Zhou, D., Huang, C., Lin, Z., et al. (2014) Macrophage Polarization and Function Emphasize the Evolving Roles of Coordinated Regulation of Cellular Signaling Pathways. Cell Signal, 26, 192-197. [Google Scholar] [CrossRef] [PubMed]
[39] Zhang, N., Duan, W.D., Leng, J.J., Zhou, L., Wang, X., Xu, Y.Z., Wang, X.D., Zhang, A.Q. and Dong, J.H. (2015) STAT3 Regulates the Migration and Invasion of a Stem-Like Subpopulation through microRNA-21 and Multiple Targets in Hepatocellular Carcinoma. Oncology Reports, 33, 1493-1498. [Google Scholar] [CrossRef] [PubMed]
[40] Wang, B., Majumder, S., Nuovo, G., Kutay, H., Olivia, S., Patel, T., Schmittgen, T.D., Croce, C., Ghoshal, K. and Jacob, S.T. (2009) Role of microRNA-155 at Early Stages of Hepatocarcinogenesis Induced by Choline-Deficient and Amino Acid-Defined Diet in C57BL/6 Mice. Hepatology, 50, 1152-1161. [Google Scholar] [CrossRef] [PubMed]
[41] Li, X.Q., Ren, Z.X., Li, K., Huang, J.J., Huang, Z.T., Zhou, T.R., Cao, H.Y., Zhang, F.X. and Tan, B. (2018) Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis. International Journal of Molecular Sciences, 19, 675. [Google Scholar] [CrossRef] [PubMed]
[42] Ye, Y., Xu, Y., Lai, Y., et al. (2018) Long Noncoding RNA Cox-2 Prevents Immune Evasion and Metastasis of Hepatocellular Carcinoma by Altering M1/M2 Macrophage Polarization. Journal of Cellular Biochemistry, 119, 2951-2963. [Google Scholar] [CrossRef] [PubMed]
[43] Marquardt, J.U. (2018) The Role of Transforming Growth Factor-beta in Human Hepatocarcinogenesis: Mechanistic and Therapeutic Implications from an Integrative Multiomics Approach. Gastroenterology, 154, 17-20. [Google Scholar] [CrossRef] [PubMed]
[44] Merdrignac, A., Angenard, G., Allain, C., Petitjean, K., Berget, D., Bellaud, P., Fautrel, A., Turlin, B., Clement, B., Dooley, S., et al. (2018) A Novel Transforming Growth Factor Beta-Induced Long Noncoding RNA Promotes an Inflammatory Microenvironment in Human Intrahepatic Cholangiocarcinoma. Hepatology Communications, 2, 254-269. [Google Scholar] [CrossRef] [PubMed]
[45] Yuan, J.H., Yang, F., Wang, F., Ma, J.Z., Guo, Y.J., Tao, Q.F., Liu, F., Pan, W., Wang, T.T., Zhou, C.C., et al. (2014) A Long Noncoding RNA Activated by TGF-beta Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma. Cancer Cell, 25, 666-681. [Google Scholar] [CrossRef] [PubMed]
[46] Almajhdi, F.N., Al-Quadri, A.Y. and Hussain, Z. (2013) Differential Expression of Transforming Growth Factor-beta1 and HBx Enhances Hepatitis B Virus Replication and Augments Host Immune Cytokines and Chemokines. Annals of Hepatology, 12, 408-415. [Google Scholar] [CrossRef
[47] Xiang, W.Q., Feng, W.F., Ke, W., Sun, Z., Chen, Z. and Liu, W. (2011) Hepatitis B Virus X Protein Stimulates IL-6 Expression in Hepatocytes via a MyD88-Dependent Pathway. Journal of Hepatology, 54, 26-33. [Google Scholar] [CrossRef] [PubMed]
[48] Sheng, T., Wang, B., Deng, B., Qu, L., Qi, X.S., Wang, X.L., Deng, G.L. and Sun, X. (2015) The Relationship between Serum Interleukin-6 and the Recurrence of Hepatitis b Virus-Related Hepatocellular Carcinoma after Curative Resection. Medicine (Baltimore), 94, e941. [Google Scholar] [CrossRef
[49] Xia, L., Tian, D., Huang, W., Zhu, H., Wang, J., Zhang, Y., Hu, H., Nie, Y., Fan, D. and Wu, K. (2012) Upregulation of IL-23 Expression in Patients with Chronic Hepatitis B Is Mediated by the HBx/ERK/NF-kB Pathway. The Journal of Immunology, 188, 753-764. [Google Scholar] [CrossRef] [PubMed]
[50] Wang, D., Zou, L., Liu, X., Zhu, H. and Zhu, R. (2016) Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis b Virus x Protein. Pathology and Oncology Research, 22, 393-399. [Google Scholar] [CrossRef] [PubMed]
[51] Tangkijvanich, P., Thong-Ngam, D., Mahachai, V., Theamboonlers, A. and Poovorawan, Y. (2007) Role of Serum Interleukin-18 as a Prognostic Factor in Patients with Hepatocellular Carcinoma. World Journal of Gastroenterology, 13, 4345-4349. [Google Scholar] [CrossRef] [PubMed]
[52] Liu, K.G., Shao, X.L., Xie, H.H., Xu, L., Zhao, H., Guo, Z.H., Li, L. and Liu, J. (2010) The Expression of Hepatitis B Virus X Protein and Cyclooxygenase-2 in Hepatitis B Virus-Related Hepatocellular Carcinoma: Correlation with Microangiogenesis and Metastasis, and What Is the Possible Mechanism. Chinese Journal of Hepatology, 18, 831-836.
[53] Zheng, B.Y., Fang, X.F., Zou, L.Y., Huang, Y.H., Chen, Z.X., Li, D., Zhou, L.Y., Chen, H. and Wang, X.Z. (2014) The Co-Localization of HBx and COXIII Upregulates COX-2 Promoting HepG2 Cell Growth. International Journal of Oncology, 45, 1143-1150. [Google Scholar] [CrossRef] [PubMed]
[54] Yang, Z.F. and Poon, R.T. (2008) Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record (Hoboken), 291, 721-734. [Google Scholar] [CrossRef] [PubMed]
[55] Yu, D., Sun, X., Qiu, Y., et al. (2007) Identification and Clinical Significance of Mobilized Endothelial Progenitor Cells in Tumor Vasculogenesis of Hepatocellular Carcinoma. Clinical Cancer Research, 13, 3814-3824. [Google Scholar] [CrossRef
[56] Itano, N., Zhuo, L. and Kimata, K. (2008) Impact of the Hyaluronan-Rich Tumor Microenvironment on Cancer Initiation and Progression. Cancer Science, 99, 1720-1725. [Google Scholar] [CrossRef] [PubMed]
[57] Lewis, C.E. and Pollard, J.W. (2006) Distinct Role of Macrophages in Different Tumor Microenvironments. Cancer Research, 66, 605-612. [Google Scholar] [CrossRef
[58] Song, G., Ohashi, T., Sakamoto, N. and Sato, M. (2006) Adhesive Force of Human Hepatoma HepG2 Cells to Endothelial Cells and Expression of E-Selectin. Molecular and Cellular Biomechanics, 3, 61-68.
[59] Liu, L., Zhu, X.D., Wang, W.Q., et al. (2010) Activation of Beta-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis. Clinical Cancer Research, 16, 2740-2750. [Google Scholar] [CrossRef
[60] Polyak, K. and Weinberg, R.A. (2009) Transitions between Epithelial and Mesenchymal States: Acquisition of Malignant and Stem Cell Traits. Nature Reviews Cancer, 9, 265-273. [Google Scholar] [CrossRef] [PubMed]
[61] Ren, T., Zhu, L. and Cheng, M. (2017) CXCL10 Accelerates EMT and Metastasis by MMP-2 in Hepatocellular Carcinoma. American Journal of Translational Research, 9, 2824-2837.
[62] Cui, X., Li, Z., Gao, J., Gao, P.J., Ni, Y.B. and Zhu, J.Y. (2016) Elevated CXCL1 Increases Hepatocellular Carcinoma Aggressiveness and Is Inhibited by miRNA-200a. Oncotarget, 7, 65052-65066. [Google Scholar] [CrossRef] [PubMed]
[63] Lin, H., Yang, B. and Teng, M. (2017) T-Cell Immunoglobulin Mucin-3 as a Potential Inducer of the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Oncology Letters, 14, 5899-5905. [Google Scholar] [CrossRef] [PubMed]
[64] Liu, Y., Liu, Y., Yan, X., Xu, Y., Luo, F., Ye, J., Yan, H., Yang, X., Huang, X., Zhang, J., et al. (2014) HIFs Enhance the Migratory and Neoplastic Capacities of Hepatocellular Carcinoma Cells by Promoting EMT. Tumor Biology, 35, 8103-8114. [Google Scholar] [CrossRef] [PubMed]
[65] Wang, Z., Luo, L., Cheng, Y., et al. (2018) Correlation between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood. Journal of Gastrointestinal Surgery, 22, 633-639. [Google Scholar] [CrossRef] [PubMed]
[66] Castven, D., Czauderna, C. and Marquardt, J.U. (2017) Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance. In: Villanueva, A., Ed., Resistance to Molecular Therapies for Hepatocellular Carcinoma, Springer International Publishing, Cham, Volume 13, 65-91. [Google Scholar] [CrossRef
[67] Nowak, M.A., Bonhoeffer, S., Hill, A.M., Boehme, R., Thomas, H.C. and McDade, H. (1996) Viral Dynamics in Hepatitis B Virus Infection. Proceedings of the National Academy of Sciences of the United States of America, 93, 4398. [Google Scholar] [CrossRef] [PubMed]
[68] Junttila, M.R. and de Sauvage, F.J. (2013) Influence of Tumor Micro-Environment Heterogeneity on Therapeutic Response. Nature, 501, 346-354. [Google Scholar] [CrossRef] [PubMed]
[69] Iliopoulos, D., Hirsch, H.A., Wang, G. and Struhl, K. (2011) Inducible Formation of Breast Cancer Stem Cells and Their Dynamic Equilibrium with Non-Stem Cancer Cells via IL6 Secretion. Proceedings of the National Academy of Sciences of the United States of America, 108, 1397. [Google Scholar] [CrossRef] [PubMed]
[70] Tsuda, A., Chow, A., Wu, J., Somlo, G., Chu, P., Loera, S., Luu, T., Li, A.X., Wu, X., Ye, W., et al. (2012) CCL2 Mediates Crosstalk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells. Cancer Research, 72, 2768. [Google Scholar] [CrossRef
[71] Todaro, M., Gaggianesi, M., Catalano, V., Benfante, A., Iovino, F., Biffoni, M., Apuzzo, T., Sperduti, I., Volpe, S., Cocorullo, G., et al. (2014) CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis. Cell Stem Cell, 14, 342-356. [Google Scholar] [CrossRef] [PubMed]
[72] Cui, Y., Sun, S., Ren, K., Quan, M., Song, Z., Zou, H., Li, D. and Cao, J. (2016) Reversal of Liver Cancer-Associated Stellate Cell-Induced Stem-Like Characteristics in SMMC-7721 Cells by 8-Bromo-7-methoxy Chrysin via Inhibiting STAT3 Activation. Oncology Reports, 35, 2952-2962. [Google Scholar] [CrossRef] [PubMed]
[73] Chen, A., Xu, C., Luo, Y., Liu, L., Song, K., Deng, G., Yang, M., Cao, J., Yuan, L. and Li, X. (2019) Disruption of Crosstalk between LX-2 and Liver Cancer Stem-Like Cells from MHCC97H Cells by DFOG via Inhibiting FOXM1. Acta Biochimica et Biophysica Sinica, 51, 1267-1275. [Google Scholar] [CrossRef] [PubMed]
[74] Sica, A., Porta, C., Amadori, A. and Pastò, A. (2017) Tumor-Associated Myeloid Cells as Guiding Forces of Cancer Cell Stemness. Cancer Immunology, Immunotherapy, 66, 1025-1036. [Google Scholar] [CrossRef] [PubMed]
[75] Otvos, B., Silver, D.J., Mulkearns-Hubert, E.E., Alvarado, A.G., Turaga, S.M., Sorensen, M.D., Rayman, P., Flavahan, W.A., Hale, J.S., Stoltz, K., et al. (2016) Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid-Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion. Stem Cells, 34, 2026-2039. [Google Scholar] [CrossRef] [PubMed]
[76] Chang, T.-S., Chen, C.-L., Wu, Y.-C., Liu, J.-J., Kuo, Y.C., Lee, K.-F., Lin, S.-Y., Lin, S.-E., Tung, S.-Y., Kuo, L.-M., et al. (2016) Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS ONE, 11, e0149897. [Google Scholar] [CrossRef] [PubMed]
[77] Ng, K.-Y., Chai, S., Tong, M., Guan, X.-Y., Lin, C.-H., Ching, Y.-P., Xie, D., Cheng, A.S.-L. and Ma, S. (2016) C-Terminal Truncated Hepatitis B Virus X Protein Promotes Hepatocellular Carcinogenesis through Induction of Cancer and Stem Cell-Like Properties. Oncotarget, 7, 24005-24017. [Google Scholar] [CrossRef] [PubMed]
[78] Liu, Z., Dai, X., Wang, T., Zhang, C., Zhang, W., Zhang, W., Zhang, Q., Wu, K., Liu, F., Liu, Y., et al. (2017) Hepatitis B Virus PreS1 Facilitates Hepatocellular Carcinoma Development by Promoting Appearance and Self-Renewal of Liver Cancer Stem Cells. Cancer Letters, 400, 149-160. [Google Scholar] [CrossRef] [PubMed]
[79] Shirasaki, T., Honda, M., Yamashita, T., Nio, K., Shimakami, T., Shimizu, R., Nakasyo, S., Murai, K., Shirasaki, N., Okada, H., et al. (2018) The Osteopontin-CD44 Axis in Hepatic Cancer Stem Cells Regulates IFN Signaling and HCV Replication. Scientific Reports, 8, Article No. 13143. [Google Scholar] [CrossRef] [PubMed]
[80] Liu, H., Zhang, W., Jia, Y., Yu, Q., Grau, G.E., Peng, L., Ran, Y., Yang, Z., Deng, H. and Lou, J. (2013) Single-Cell Clones of Liver Cancer Stem Cells Have the Potential of Differentiating into Different Types of Tumor Cells. Cell Death & Disease, 4, e857. [Google Scholar] [CrossRef] [PubMed]
[81] Sukowati, C.H., Anfuso, B., Croce, L.S. and Tiribelli, C. (2015) The Role of Multipotent Cancer-Associated Fibroblasts in Hepatocarcinogenesis. BMC Cancer, 15, 188. [Google Scholar] [CrossRef] [PubMed]
[82] Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D.M., Zou, W. and Welling, T.H. (2014) Tumor-Associated Macrophages Produce Interleukin Six and Signal via STAT3 to Promote the Expansion of Human Hepatocellular Carcinoma Stem Cells. Gastroenterology, 147, 1393-1404. [Google Scholar] [CrossRef] [PubMed]
[83] Marquardt, J.U., Gomez-Quiroz, L., Arreguin Camacho, L.O., Pinna, F., Lee, Y.H., Kitade, M., Dominguez, M.P., Castven, D., Breuhahn, K., Conner, E.A., et al. (2015) Curcumin Effectively Inhibits Oncogenic NF-kappaB Signaling and Restrains Stemness Features in Liver Cancer. Journal of Hepatology, 63, 661-669. [Google Scholar] [CrossRef] [PubMed]
[84] You, N., Zheng, L., Liu, W., Zhong, X., Wang, W. and Li, J. (2014) Proliferation Inhibition and Differentiation Induction of Hepatic Cancer Stem Cells by Knockdown of BC047440: A Potential Therapeutic Target of Stem Cell Treatment for Hepatocellular Carcinoma. Oncology Reports, 31, 1911-1920. [Google Scholar] [CrossRef] [PubMed]